African Women Test Anti-HIV Gel in Phase 3 Clinical Trials
Filed in archive Drugs, Vaccines and Therapeutics by ruth on February 11, 2006

Carraguard® (formerly known as PC-515) is the Population Council's lead candidate microbicide, a gel whose active pharmaceutical ingredient is made from carrageenan, a substance derived from seaweed. Carrageenan is inexpensive and stable and has been used for hundreds of years as a thickener in foods and as an emulsifier in topical creamsand lotions.
Previous in vitro and in vivo trials have shown Carraguard to prevent HIV transmission, by lining the vaginal mucosa, thereby blocking the HIV virus from entering the cells.
This Phase 3 clinical trials are conducted to confirm that Carraguard® Gel can prevent the transmission of HIV when used during vaginal intercourse, and that the gel is safe for vaginal use. The study is expected to be concluded early 2007.
Source: Womens E-news, Photo: PopCouncil
Permalink: African Women Test Anti-HIV Gel in Phase 3 Clinical Trials
Tags:
HIV microbicide biotech phase trials phase+clinical clinical+trials women+test
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/15333






